文献速递血栓与止血

血友病A患者凝血因子VIII浓缩物半衰期的异质性源于内源性血管性血友病因子清除率的变异性

Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factor.
PubMed 文献 · J Thromb Haemost · 2023-01-20

本研究在61例成人血友病A患者中测定重组凝血因子VIII半衰期,评估多种已知影响因子VIII清除的因素。结果显示内源性血浆血管性血友病因子清除率的异质性是因子VIII半衰期变异的关键决定因素,ABO血型和年龄也显著影响因子VIII清除。因子VIII半衰期<12小时的患者年因子VIII用量显著增加(p=0.0035)。

要点

  • 内源性血管性血友病因子清除率变异是血友病A患者因子VIII半衰期异质性的主要决定因素。
  • ABO血型和年龄显著影响因子VIII清除,ABO血型效应完全通过内源性血管性血友病因子清除率介导。
  • 因子VIII半衰期<12小时的患者年因子VIII用量(IU/kg/y)显著增加(p=0.0035)。

核心结论

  • 血友病A患者因子VIII浓缩物半衰期的异质性主要归因于内源性血管性血友病因子清除率的变异性。

研究设计与样本

  • 在61例成人血友病A患者队列中测定重组因子VIII半衰期,并评估多种已报道的因子VIII清除修饰因素(包括血浆血管性血友病因子抗原和血管性血友病因子前肽水平、血管性血友病因子-因子VIII结合能力、ABO血型和非中和性抗因子VIII抗体),对血管性血友病因子基因的因子VIII结合区域进行测序,并研究因子VIII半衰期变异对临床表型的影响。

主要发现

  • 内源性血浆血管性血友病因子清除的异质性是血友病A患者因子VIII半衰期变异的关键决定因素。
  • ABO血型和年龄均显著影响因子VIII清除;ABO血型对因子VIII半衰期的影响完全通过其对内源性血管性血友病因子清除率的作用来调节,而年龄相关效应对因子VIII清除至少部分不依赖血管性血友病因子。
  • 与既往研究相反,未观察到血管性血友病因子-因子VIII结合亲和力变异对因子VIII清除的主要影响。
  • 26%的血友病A患者中观察到高滴度免疫球蛋白G抗体(≥1:80),但这些抗体未影响因子VIII半衰期。
  • 因子VIII半衰期<12小时的患者年因子VIII用量(IU/kg/y)显著增加(p=0.0035)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have reported marked interindividual variation in factor VIII (FVIII) clearance in patients with hemophilia (PWH) and proposed a number of factors that influence this heterogeneity. OBJECTIVES: To investigate the importance of the clearance rates of endogenous von Willebrand factor (VWF) compared with those of other FVIII half-life modifiers in adult PWH. METHODS: The half-life of recombinant FVIII was determined in a cohort of 61 adult PWH. A range of reported modifiers of FVIII clearance was assessed (including plasma VWF:antigen and VWF propeptide levels; VWF-FVIII binding capacity; ABO blood group; and nonneutralizing anti-FVIII antibodies). The FVIII-binding region of the VWF gene was sequenced. Finally, the effects of variation in FVIII half-life on clinical phenotype were investigated. RESULTS: We demonstrated that heterogeneity in the clearance of endogenous plasma VWF is a key determinant of variable FVIII half-life in PWH. Both ABO blood group and age significantly impact FVIII clearance. The effect of ABO blood group on FVIII half-life in PWH is modulated entirely through its effect on the clearance rates of endogenous VWF. In contrast, the age-related effect on FVIII clearance is, at least in part, VWF independent. In contrast to previous studies, no major effects of variation in VWF-FVIII binding affinity on FVIII clearance were observed. Although high-titer immunoglobulin G antibodies (≥1:80) were observed in 26% of PWH, these did not impact FVIII half-life. Importantly, the annual FVIII usage (IU/kg/y) was significantly (p = .0035) increased in patients with an FVIII half-life of <12 hours. CONCLUSION: Our data demonstrate that heterogeneity in the half-life of FVIII concentrates in patients with hemophilia A is primarily attributable to variability in the clearance of endogenous VWF.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Elsheikh E, Lavin M, Heck LA, et al. Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factor. J Thromb Haemost. 2023. PMID: 36775768. doi:10.1016/j.jtha.2023.01.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。